The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Tbh SGS are supposed to accelerate trials to market… once we hear the commercialisation deal hopefully this will fly… however thought it would on trial news… don’t know why I am still shocked how AIM shares react… nothing guaranteed!!
Where does it say Phase 3 Trial… read the RNS’s on successful completion of The Trial that has just completed… we will be going to commercialisation!!! Further trials will take place for additional treatments using AZD1656!
Not sure why people are talking about Phase 3 - the trials for AZD1656 being used for diabetics with Covid is completed…. However further trials for the use of AZD1656 in treatment against Covid for all will be going ahead which is excellent news. So unless someone can show evidence of Phase 3 can we not keep going on about it… We are ready to go to commercialisation as in the product is ready to sell!!
Lord sutch… SGS didn’t buy the shares it was in the deal!! The shares are done and dusted and new investors have taken them on… these would probably be large investors even though the amounts are small here, seeing the potential they may want to invest more as well.
I think all new and existing investors should watch this Sir Chris Evans interview… the guy is a genius! We will do very well by Chris… https://youtu.be/9wMizV1KG-M
All the years I have been trading have not seen a morning like that on such transformational news… just shows how unregulated AIM is and MMs do as they please… attempting to fill there pockets… will have to try harder… looking at a big rise this afternoon as on the turn!!